Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p86
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 86/312)
Character Range: 16002429–16012713

be aged 70 years or older;
                                                                                                                           Patient must have a Bone Mineral Density (BMD) T-score of -2.5 or less; AND
                                                                                                                           Patient must not receive concomitant treatment with any other PBS-subsidised anti-resorptive agent for this condition.
                                                                                                                           The date, site (femoral neck or lumbar spine) and score of the qualifying BMD measurement must be documented in the patient's medical records when treatment is initiated.
C15012              P15012         CN15012          Desmopressin                                                           Cranial diabetes insipidus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 15012
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient.
C15015              P15015         CN15015          Testosterone                                                           Androgen deficiency                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have an established pituitary or testicular disorder; AND
                                                                                                                           Must be treated by a specialist general paediatrician, specialist paediatric endocrinologist, specialist urologist, specialist endocrinologist or a Fellow of the Australasian Chapter of Sexual Health Medicine; or in consultation with one of these specialists; or have an appointment to be assessed by one of these specialists.
                                                                                                                           The name of the specialist must be included in the authority application.
C15017              P15017         CN15017          Bromocriptine                                                          Pathological hyperprolactinaemia
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have had radiotherapy for this condition with incomplete resolution.
C15018              P15018         CN15018          Dutasteride                                                            Benign prostatic hyperplasia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Authority Required procedures - Streamlined Authority Code 15018
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must have lower urinary tract symptoms; AND
                                                                                                                           Patient must have moderate to severe benign prostatic hyperplasia; AND
                                                                                                                           The treatment must be in combination with an alpha-antagonist.
C15024              P15024         CN15024          Alendronic acid with colecalciferol                                    Corticosteroid-induced osteoporosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 15024
                                                                                                                           The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
                                                                                                                           Patient must currently be on long-term (at least 3 months), high-dose (at least 7.5 mg per day prednisolone or equivalent) corticosteroid therapy; AND
                                                                                                                           Patient must have a Bone Mineral Density (BMD) T-score of -1.5 or less; AND
                                                                                                                           Patient must not receive concomitant treatment with any other PBS-subsidised anti-resorptive agent for this condition.
                                                                                                                           The duration and dose of corticosteroid therapy together with the date, site (femoral neck or lumbar spine) and score of the qualifying BMD measurement must be documented in the patient's medical records when treatment is initiated.
C15025              P15025         CN15025          Desmopressin                                                           Primary nocturnal enuresis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority